Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 3,960 | 3,564 | 164 | 258 | 2 |
| Gross Profit | 3,960 | 3,564 | 164 | 258 | 2 |
| Operating Expenses | 9,991 | 5,997 | 6,578 | 7,935 | 4,082 |
| Operating Income | -6,031 | -2,433 | -6,415 | -7,677 | -4,080 |
| Other Income | 325 | 317 | 320 | 370 | 444 |
| Pre-tax Income | -5,706 | -2,116 | -6,095 | -7,307 | -3,636 |
| Net Income Continuous | -5,709 | -2,116 | -6,095 | -7,307 | -2,916 |
| Net Income | $-5,709 | $-2,116 | $-6,095 | $-7,307 | $-2,916 |
| EPS Basic Total Ops | -0.34 | -0.13 | -0.36 | -0.44 | -0.18 |
| EPS Basic Continuous Ops | -0.34 | -0.13 | -0.36 | -0.44 | -0.17 |
| EPS Diluted Total Ops | -0.34 | -0.13 | -0.36 | -0.44 | -0.18 |
| EPS Diluted Continuous Ops | -0.34 | -0.13 | -0.36 | -0.44 | -0.17 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.10 | -0.36 | -0.44 | -0.18 |
| EBITDA(a) | $-6,024 | $-2,426 | $-6,408 | $-7,670 | $-4,074 |